Bevacizumab, Everolimus, and Erlotinib in Treating Patients With Advanced Solid Tumors

NCT00276575 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

65

Enrollment

OTHER

Sponsor class

Conditions

Unspecified Adult Solid Tumor, Protocol Specific

Interventions

BIOLOGICAL: bevacizumab
DRUG: erlotinib hydrochloride
DRUG: everolimus

Sponsor

Herbert Hurwitz, MD

Collaborators

[object Object]